Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

At 211 monoclonal antibody 81C6

A radioimmunoconjugate of a human-murine chimeric IgG2 monoclonal antibody (MoAb) 81C6 labeled with an alpha-emitting radionuclide Astatine 211 (At-211), with imaging and radioimmunotherapeutic properties. MoAb 81C6 recognizes the extracellular matrix antigen tenascin (hexabrachion), which is up-regulated in gliomas and other cancers. Using MoAb 81C6 as a carrier for At-211 results in the targeted imaging and/or destruction of cells expressing tenascin.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	astatine 211 conjugated 81C6 anti-tenascin monoclonal antibody astatine At 211 MOAB 81C6 astatine At 211 monoclonal antibody 81C6 astatine-211 labelled anti-tenascin monoclonal antibody 81C6

At 211 monoclonal antibody 81C6

Search NCI's Drug Dictionary